Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Share News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.70
Bid: 12.40
Ask: 13.00
Change: -0.05 (-0.39%)
Spread: 0.60 (4.839%)
Open: 13.00
High: 13.00
Low: 12.40
Prev. Close: 12.75
POLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-up

Mon, 12th Feb 2024 19:44

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Metals One PLC - Finland and Norway-focused developer of brownfield metals projects - Reports results from eight diamond drillholes at the R1 Hook target, located within the Rauta 9-11 licence area at the Black Schist Project in Finland. Says significant intersections of mineralised black schists were identified in all eight drill holes, whilst drilling has also demonstrated geological continuity with the company's existing Resource at R1 which could support future resource expansion.

----------

Beacon Energy PLC - Isle of Man-registered oil and gas company - Provides operational update on the Schwarzbach-2 well in the Erfelden field. Reports the sand jetting operation with a coiled tubing unit has now been completed. Expects to recommence production in the coming days following reinstallation of the rod pump. States the impact of the sand jetting will only be known once production has been restored and a stabilised and sustained flow rate from the rod pump has been achieved, at which time the company will provide an update. Once the well has been fully cleaned up following the sand jetting operations, it is expected that the rod pump will be replaced with an electrical submersible pump to maximise production - this is currently scheduled to take place in April 2024.

----------

Baron Oil PLC - London-based oil and gas exploration and appraisal company - Updates on operational activities on the TL-SO-19-16 production sharing contract, offshore Democratic Republic of Timor-Leste. Notes Baron's wholly owned subsidiary, SundaGas Banda Unipessoal Lda, has entered into contracts to conduct a survey at the planned drilling location for the Chuditch-2 appraisal well. Site survey operations are expected to be carried out at the location during February and early March 2024. Explains the objective of the site survey is principally to identify any potential hazards at the proposed well site, ensuring that a drilling rig can be safely located there with minimal environmental impact.

----------

Star Energy Group PLC - onshore energy company - Announces updated competent persons report for its conventional oil and gas interests. Reports proven reserves net present value of USD143 million at December 31, little changed from USD144 million in 2021. Says total of proven and probable reserves was USD235 million at December 31, rising from USD215 million in 2021.

----------

Poolbeg Pharma PLC - London-based clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need - Says independent research conducted on behalf of Poolbeg confirms a more than USD10 billion market opportunity for POLB 001 in cancer immunotherapy-induced cytokine release syndrome as an orally delivered preventative therapy. Believes rare and orphan diseases represent a significant value creation opportunity. Sees a substantial opportunity for medicines to treat these severe and often chronic conditions. Anticipates that acquiring and commercialising rare and orphan drugs could potentially lead to attractive revenue generation opportunities.

----------

Kromek Group PLC - Sedgefield, England-based detection technology supplier - Agrees to allot new shares to another two loan note holders in consideration of them cancelling their loan notes that were due to expire later this month. This follows loan note conversion announced last Monday. The two further loan note holders will cancel their loan notes, which total GBP1.2 million, including accrued interest. Kromek agrees to allot around 16.5 million shares in consideration of the cancellation at 7.5 pence per share. The cancellation is subject to shareholder approval.

----------

Katoro Gold PLC - London-based gold and nickel exploration and development company - Raises GBP750,000 via broker-led placing and subscription with new and existing shareholders to support business development at 0.1 pence per share. Plans changes to board to maximise value from existing interests and to secure new cost-effective opportunities globally, with a focus on critical metals including uranium. Appoints strategic consultant, Paul Johnson, former chief executive of Power Metal Resources PLC and Metal Tiger PLC, to assist the board with a reinvigoration of the business model, business operations, strategic direction and enhanced communications with investors. Plans name change to Katoro Global Resources PLC.

----------

Enteq Technologies PLC - Ascot, England-based energy services technology and equipment supplier - Provides an update on the progress of the SABER Tool technology. Expects to receive USD100,000 in the first half of financial 2025 from contract win.

----------

Silverwood Brands PLC - holding company established to invest primarily in branded consumer businesses - Says VSA Capital Ltd has transferred around 2.3 million shares to Chief Executive Andrew Gerrie in settlement of a legal dispute. Following this transfer, finalises arrangements for the proposed cancellation of the 228 million shares issued in connection with the acquisition of a 20% stake in Lush Cosmetics Ltd and Lush Cosmetic Warriors.

----------

Athelney Trust PLC - invests in smaller UK companies for dividend and capital growth - Reports net asset value at December 31 was 209.1 pence, down 4.7% from 219.4p the year before. Recommends final dividend of 7.6p, making a total payout of 9.8p, increased from 9.6p, a rise of 2.0%. NAV total return was negative 4.4% compared to negative 26.2% the year before. Describes the year as "disappointing". Notes the company suffered negative absolute returns and has underperformed compared to the FTSE 250 largely because of ongoing negative sentiment for UK smaller companies and comparatively high UK interest rates through the year. But, believes there is now a strong case for investment in UK equities....which "offer great value for money".

----------

RTW Biotech Opportunities Ltd - London-based venture capital firm focused on biotechnology companies - Notes Arix shareholders vote to place Arix Bioscience PLC into voluntary liquidation. Following this, the assets of Arix have been transferred to RTW in exchange for the issue of new ordinary shares in RTW Bio to eligible Arix shareholders. In November, RTW agreed to acquire the entirety of Arix's assets, with shareholders receiving 1.4633 RTW shares for each share in the company. RTW also provided a cash exit to Arix's largest shareholder, Acacia Research Corp, which has been given a total of USD57.1 million in exchange for its 26% stake in the company.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
6 Jun 2024 14:52

UK shareholder meetings calendar - next 7 days

Friday 7 June 
Property Franchise Group PLCAGM
Trident Royalties PLCAGM
TruSpine Technologies PLCAGM
Monday 10 June 
Aterian PLCAGM
Griffin Mining LtdAGM
Lok'n Store Group PLCGM re takeover by Shurgard
Onward Opportunities LtdAGM
Oxford Nanopore Technologies PLCAGM
Pan African Resources PLCGM re capital reduction
Tuesday 11 June 
Ebiquity PLCAGM
Flowtech Fluidpower PLCAGM
MaxCyte IncAGM
Mobico Group PLCAGM
Newbury Racecourse PLCAGM
Nightcap PLCGM re fundraise
Phoenix Digital Assets PLCGM re up to GBP33.7 million fundraise
Tirupati Graphite PLCGM requisitioned by Walpole St Andrews Nominees
Tortilla Mexican Grill PLCAGM
Tufton Oceanic Assets LtdEGM
Wednesday 12 June 
Advanced Medical Solutions Group PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Aurora Investment Trust PLCAGM
BioPharma Credit PLCAGM
Brighton Pier Group PLCAGM
Digital 9 Infrastructure PLCAGM
EPE Special Opportunities LtdAGM
Foresight Solar Fund LtdAGM
Star Energy Group PLCAGM
Thursday 13 June 
Beacon Rise Holdings PLCAGM
Christie Group PLCAGM
Everyman Media Group PLCAGM
Hochschild Mining PLCAGM
Iofina PLCAGM
Jadestone Energy PLCAGM
Panther Metals PLCAGM
Pollen Street Group LtdAGM
Poolbeg Pharma PLCAGM
Serabi Gold PLCAGM
Smurfit Kappa Group PLCGM re WestRock deal
Sound Energy PLCAGM
Starwood European Real Estate Finance LtdAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
1 May 2024 16:39

Poolbeg Pharma celebrates full patent approval for Immunomodulator II

(Alliance News) - Poolbeg Pharma PLC on Wednesday said that it has received a fully granted patent from the US Patent Office for its Immunomodulator II patent application.

Read more
30 Apr 2024 16:43

Poolbeg agrees 12-month option over potential Behcet's treatment

(Sharecast News) - Poolbeg Pharma announced an exclusive 12-month option agreement with Silk Road Therapeutics on Tuesday, to potentially acquire a novel topical muco-adherent formulation of Pentoxifylline (tPTX).

Read more
30 Apr 2024 16:30

EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
20 Mar 2024 16:18

EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
20 Mar 2024 11:10

Poolbeg Pharma to be granted US patent

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced on Wednesday that it has received a notice of allowance from the US Patent Office regarding its immunomodulator II patent application.

Read more
19 Feb 2024 14:22

Director dealings: Poolbeg Pharma co-founder ups stake

(Sharecast News) - Poolbeg Pharma revealed on Monday that chairman Cathal Friel had acquired 830,000 ordinary shares in the AIM-listed biopharmaceutical company.

Read more
15 Feb 2024 16:02

TRADING UPDATES: Diversified Energy offers dividend alternative

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
12 Feb 2024 14:37

Poolbeg upbeat on research into potential drug market

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced findings from independent research confirming a substantial market opportunity exceeding $10bn for its drug candidate POLB 001 on Monday, in preventing cancer immunotherapy-induced cytokine release syndrome (CRS) through oral delivery.

Read more
17 Jan 2024 13:58

Poolbeg Pharma hails POLB 001'S potential to treat CRS

(Alliance News) - Poolbeg Pharma PLC on Wednesday noted "promising" results for POLB 001's potential in treating cancer immunotherapy-induced cytokine release syndrome.

Read more
20 Dec 2023 20:00

TRADING UPDATES: K3 Business says cash balances ahead of forecast

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
20 Dec 2023 13:54

Poolbeg makes promising progress with RSV programme

(Sharecast News) - Poolbeg Pharma revealed promising results from the lab-based analysis and prioritisation of respiratory syncytial virus (RSV) drug targets and treatments on Wednesday, driven by its artificial intelligence (AI) programme.

Read more
21 Nov 2023 14:39

TRADING UPDATES: Poolbeg hails approval; EDX links with Thermo Fisher

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
9 Nov 2023 16:57

IN BRIEF: Poolbeg Pharma appoints former Amryt executives to team

Poolbeg Pharma PLC - Clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need - Appoints a number of former executives of Amryt Pharma PLC to its leadership team. Poolbeg's Chair, Cathal Friel, co-founded both Poolbeg and Amryt Pharma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.